Saltar ao contenido
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avanzado
  • Benefits of pain relief on fat...
  • Citar
  • Text this
  • Enviar este rexistro por email
  • Imprimir
  • Exportar rexistro
    • Exportar a RefWorks
    • Exportar a EndNoteWeb
    • Exportar a EndNote
  • Permanent link
Benefits of pain relief on fatigue, function, and quality of life when joint inflammation is controlled in patients with RA

Benefits of pain relief on fatigue, function, and quality of life when joint inflammation is controlled in patients with RA

Detalles Bibliográficos
Main Authors: Van De Laar, M, Pope, J, Lee, Y, Fautrel, B, Ikeda, K, Quebe, A, Zhang, X, Gaich, C, De Leonardis, F, Lisse, J, Workman, J, Taylor, P
Formato: Conference item
Publicado: BMJ Publishing Group 2019
  • Existencias
  • Descripción
  • Títulos similares
  • Staff View

Títulos similares

  • Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM
    por: Fautrel, B, et al.
    Publicado: (2019)
  • Achieving pain control in rheumatoid arthritis with baricitinib or ddalimumab plus methotrexate: Results from the RA-BEAM Trial
    por: Taylor, P, et al.
    Publicado: (2019)
  • Improved patient-reported outcomes in patients with rheumatoid arthritis who failed adalimumab or placebo treatment and were rescued with baricitinib
    por: Fautrel, B, et al.
    Publicado: (2017)
  • Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors
    por: Taylor, P, et al.
    Publicado: (2019)
  • Comparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC)
    por: Fautrel, B, et al.
    Publicado: (2018)

Opciones de procura

  • Historial de Procuras
  • Procura avanzada

Buscar Máis

  • Revisar o catálogo
  • Lista alfabética
  • Explore Channels
  • Reservas de curso
  • Novos exemplares

Necesita Axuda?

  • Consello de procura
  • Consulte a un Bibliotecario
  • Preguntas Frecuentes